Anti–LAG-3 Antibody LBL-007 plus Tislelizumab and Chemotherapy as First-Line Therapy for Advanced Nasopharyngeal Carcinoma: A Multicenter Phase 2 Trial
Year: 2025
Type: article
Language: en
Topic: Cancer Immunotherapy and Biomarkers
Authors and affiliations:
raw_author_name: Dongchen Sun
raw_affiliation_strings: 1Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
2State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
Sun Yat-sen University Cancer Center 2 Guangzhou
raw_author_name: Gang Chen
raw_affiliation_strings: 1Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
2State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
Sun Yat-sen University Cancer Center 3 Guangzhou, guangdong
raw_author_name: Yu Chen
raw_affiliation_strings: 3Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Provincial Cancer Hospital, Fuzhou, China
Fujian Provincial Cancer Hospital 4 Fuzhou, Fujian
raw_author_name: Song Qu
raw_affiliation_strings: 4Department of Radiation Oncology, Tumor Hospital of Guangxi Medical University, Nanning, China
Tumor Hospital of Guangxi Medical University 5 guangxi, State
raw_author_name: Lei Liu
raw_affiliation_strings: 5Department of Head and Neck Oncology, Cancer Center, West China Hospital of Sichuan University, Chengdu, China
Sichuan University 6 Chengdu, Sichuan
raw_author_name: Kunyu Yang
raw_affiliation_strings: 6Department of Head and Neck Oncology, Union Hospital Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Huazhong University of Science and Technology 7
raw_author_name: Jingao Li
raw_affiliation_strings: 7Department of Head and Neck Radiation Oncology, Jiangxi Provincial Cancer Hospital, Nanchang, China
Jiangxi Provincial Cancer Hospital 8 Nanchang, Jiangxi
raw_author_name: Lisha Chen
raw_affiliation_strings: 8Department of Head and Neck Radiation Oncology, Fujian Provincial Cancer Hospital, Fuzhou, China
Fujian Provincial Cancer Hospital 9
raw_author_name: Xiaoming Huang
raw_affiliation_strings: 9Department of Otolaryngology Head and Neck Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
Sun Yat-sen Memorial Hospital 10
raw_author_name: Haisheng Zhu
raw_affiliation_strings: 10Department of Oncology, The First People’s Hospital of Yulin City, Yulin, China
The First People's Hospital of Yulin CityChina
raw_author_name: Wenjun Tang
raw_affiliation_strings: 11Department of Medical Oncology, The Second Affiliated Hospital of Hainan Medical University, Haikou, China
Hainan Medical University 12 haikou, hainan
raw_author_name: Rensheng Wang
raw_affiliation_strings: 12Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
First Affiliated Hospital of GuangXi Medical University 13 Nanning, Guangxi Province
raw_author_name: Yaqian Han
raw_affiliation_strings: 13Department of Head and Neck Radiation Oncology, Hunan Cancer Hospital, Changsha, China
Central South University 14 Changsha
raw_author_name: Desheng Hu
raw_affiliation_strings: 14Department of Head and Neck Radiation Oncology, Hubei Cancer Hospital, Wuhan, China
Hubei Cancer Hospital 15
raw_author_name: Jin Gao
raw_affiliation_strings: 15Department of Radiation Oncology, Anhui Provincial Hospital, Hefei, China
Anhui Provincial Hospital hefei, Anhui China
raw_author_name: Xiaozhong Chen
raw_affiliation_strings: 16Department of Head and Neck Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, China
Zhejiang Cancer Hospital 17 杭州, 浙江
raw_author_name: Hailin Xiong
raw_affiliation_strings: 17Department of Medical Oncology, Huizhou Central People’s Hospital, Huizhou, China
Huizhou Central People's Hospital 18 Huizhou City, Guandong Province
raw_author_name: Wu Chen
raw_affiliation_strings: 18Nanjing Leads Biolabs Co., Ltd., Nanjing, China
Nanjing Leads Biolabs Co., LtdChina
raw_author_name: Bin Fan
raw_affiliation_strings: 18Nanjing Leads Biolabs Co., Ltd., Nanjing, China
Nanjing Leads Biolabs Co., Ltd. Nanjing China
raw_author_name: Shengli Cai
raw_affiliation_strings: 18Nanjing Leads Biolabs Co., Ltd., Nanjing, China
Nanjing Leads Biolabs Co., Ltd. Nanjing, Jiangsu China
raw_author_name: Xiaoqiang Kang
raw_affiliation_strings: 18Nanjing Leads Biolabs Co., Ltd., Nanjing, China
Nanjing Leads Biolabs Co., Ltd.China
raw_author_name: Li Zhang
raw_affiliation_strings: 1Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
2State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
Sun Yat-sen University Cancer Center 23 Guangzhou, Guangdong
raw_author_name: Yunpeng Yang
raw_affiliation_strings: 1Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China
2State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China
State Key Laboratory of Oncology in South China Guangzhou, Guangdong China